Skip to main content
. 2020 Oct 24;2020(10):CD013256. doi: 10.1002/14651858.CD013256.pub2

Appau 2008.

Study characteristics
Methods Retrospective cohort. Study period: 1998 to 2007.
Participants Country: USA. CD patients who underwent ileocolonic resection with anastomosis.
Interventions 1. Preoperative infliximab (n= 60) within 3 months of surgery
2. No preoperative infliximab (n=329)
Outcomes Wound infection, wound complications, anastomotic leak, sepsis and intraabdominal abscess within 30 days of surgery
Notes NOS low risk of bias overall
A djusted OR s for infliximab, 6MP/azathioprine/ methotrexate, and steroids were obtained from multivariate logistic regression model.
Risk of bias
Bias Authors' judgement Support for judgement
Representativeness of the exposed cohort Low risk CD database of all patients who underwent ileocolonic resection at the Cleveland Clinic
Selection of the non exposed cohort Low risk Both groups obtained from the same hospital and time period
Ascertainment of exposure Low risk Medication use verified with pharmacy department and patients were called to confirm last dose of infliximab infusion
Demonstration that outcome of interest was not present at start of study High risk Some patient were noted to have intraabdominal abscesses preoperatively
Comparability of cohorts (Controlled for critical factor/other medications) Low risk Adjusted for methotrexate, 6‐mercaptopurine, azathioprine, infliximab and steroid use
Comparability of cohorts (Controlled for additional factor) Low risk Also adjusted for age, gender, comorbidities, penetrating abscess before surgery, diverting stoma, and disease phenotype
Assessment of outcome Low risk Medical charts were reviewed
Was follow‐up long enough for outcomes to occur Low risk 30 days
Adequacy of follow up of cohorts Unclear risk No information was provided